Form 4: Paychex Director Kara Wilson Boosts Stake
Insider Transaction Report
Paychex Director Kara Wilson reported the acquisition of 725 common shares and 3,061 stock options, increasing her beneficial ownership in the company.
Summary
- Kara Wilson, a Director at Paychex Inc. (PAYX), reported changes in her beneficial ownership.
- On October 15, 2025, she acquired 725 shares of common stock at a price of $0, which are restricted stock units subject to vesting under the Amended and Restated 2002 Stock Incentive Plan.
- Following this acquisition, her direct beneficial ownership of common stock increased to 8,254 shares.
- Additionally, on October 15, 2025, she acquired 3,061 stock options with an exercise price of $127.52 per share.
- These newly acquired options become exercisable on October 15, 2026, and expire on October 14, 2035.
- She also holds several other tranches of stock options with varying exercise prices and expiration dates, bringing her total beneficial ownership of stock options to 46,874.
Sentiment
Score: 7
Explanation: The acquisition of restricted stock units and new stock options by a director indicates continued alignment of management interests with shareholder value and is a standard component of executive compensation.
Positives
- Director Kara Wilson increased her direct beneficial ownership of Paychex common stock by 725 shares through an RSU award, aligning her interests with shareholders.
- The acquisition of 3,061 new stock options further incentivizes the director for long-term company performance.
- The awards demonstrate continued compensation and retention of a key director, signaling stability in governance.
Future Outlook
NA
Industry Context
NA
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Equity Compensation Plan Utilization | The awards were made pursuant to the Amended and Restated 2002 Stock Incentive Plan, indicating ongoing use of the plan for director compensation. | 10/15/2025 | Reinforces the company's established compensation structure for directors, aligning their incentives with long-term company performance. |
Related Party Transactions
- The acquisition of 725 common shares (RSUs) and 3,061 stock options by Director Kara Wilson constitutes a related party transaction, as it involves compensation from the company to a member of its board. These transactions are part of the director's compensation package.
Stakeholder Impact
- Shareholders: The increase in director ownership, particularly through performance-based awards like RSUs and stock options, generally signals confidence in the company's future and aligns the director's financial interests with those of other shareholders.
Next Steps
- The restricted stock units are subject to vesting conditions.
- The newly acquired stock options will become exercisable on October 15, 2026.
Key Dates
| Date | Description |
|---|---|
| 07/13/2018 | Date exercisable for 9,615 stock options with $57.20 exercise price. |
| 07/12/2019 | Date exercisable for 8,641 stock options with $70.37 exercise price. |
| 07/11/2020 | Date exercisable for 7,929 stock options with $85.33 exercise price. |
| 07/15/2021 | Date exercisable for 5,793 stock options with $73.53 exercise price. |
| 07/15/2022 | Date exercisable for 5,075 stock options with $112.67 exercise price. |
| 07/15/2023 | Date exercisable for 3,027 stock options with $115.00 exercise price. |
| 07/15/2024 | Date exercisable for 3,382 stock options with $120.86 exercise price. |
| 07/15/2025 | Date exercisable for 3,351 stock options with $121.63 exercise price. |
| 10/15/2025 | Date of acquisition for 725 common shares (RSUs) and 3,061 stock options. |
| 10/17/2025 | Signature date of the reporting person's attorney-in-fact. |
| 07/15/2026 | Date exercisable for 670 stock options with $140.68 exercise price. |
| 10/15/2026 | Date exercisable for 3,061 stock options with $127.52 exercise price. |
| 07/12/2027 | Expiration date for 9,615 stock options with $57.20 exercise price. |
| 07/11/2028 | Expiration date for 8,641 stock options with $70.37 exercise price. |
| 07/10/2029 | Expiration date for 7,929 stock options with $85.33 exercise price. |
| 07/14/2030 | Expiration date for 5,793 stock options with $73.53 exercise price. |
| 07/14/2031 | Expiration date for 5,075 stock options with $112.67 exercise price. |
| 07/14/2032 | Expiration date for 3,027 stock options with $115.00 exercise price. |
| 07/14/2033 | Expiration date for 3,382 stock options with $120.86 exercise price. |
| 07/14/2034 | Expiration date for 3,351 stock options with $121.63 exercise price. |
| 07/14/2035 | Expiration date for 670 stock options with $140.68 exercise price. |
| 10/14/2035 | Expiration date for 3,061 stock options with $127.52 exercise price. |
Recommendation
holdWhile the insider's acquisition of shares and options is a positive signal of confidence and alignment, this Form 4 filing primarily details routine equity compensation. It does not provide new fundamental information about the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation based solely on this report. It reinforces a 'hold' position for investors who believe in the company's long-term prospects and its compensation strategy.
Keywords
Paychex, PAYX, Kara Wilson, Director, Insider Transaction, Form 4, Stock Award, Restricted Stock Units, Stock Options, Beneficial Ownership, Equity Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.